Neglected Tropical Diseases

Medicine & Life Sciences

1. 2-(pyrrolidin-2-yl)-5-(2-(4-(5-(pyrrolidin-2-yl)-1H-imidazol-2-yl)phenyl)benzofuran-5-yl)-1H-imidazole 5%
2. Africa South of the Sahara 8%
3. Anti-Bacterial Agents 6%
4. Antibodies 8%
5. Antigens 7%
6. Antimony Sodium Gluconate 8%
7. Aruba 6%
8. Aspirations (Psychology) 7%
9. Belgium 16%
10. Cambodia 32%
11. CD4 Lymphocyte Count 6%
12. Chikungunya virus 12%
13. Child 7%
14. Clinical Trials 10%
15. Cohort Studies 11%
16. Coinfection 18%
17. Confidence Intervals 6%
18. Cross-Sectional Studies 9%
19. Cutaneous Leishmaniasis 26%
20. Delivery of Health Care 5%
21. Democratic Republic of the Congo 12%
22. Disease Outbreaks 35%
23. Eastern Africa 10%
24. Ebola Hemorrhagic Fever 34%
25. Elephantiasis 9%
26. Emergencies 5%
27. Enzyme-Linked Immunosorbent Assay 6%
28. Epidemics 6%
29. Ethiopia 100%
30. Evaluation Studies 5%
31. Fever 9%
32. Genotype 10%
33. Guidelines 5%
34. Guinea 47%
35. Health Facilities 7%
36. Hepacivirus 14%
37. Hepatitis C 12%
38. HIV 44%
39. HIV Infections 13%
40. Infection 6%
41. Insect Repellents 5%
42. Leishmania 11%
43. Leishmaniasis 15%
44. Leprosy 7%
45. liposomal amphotericin B 8%
46. Malaria 13%
47. Mass Drug Administration 5%
48. Microscopy 10%
49. miltefosine 11%
50. MK-5172 5%
51. Monkeypox 6%
52. Monkeypox virus 6%
53. Mortality 8%
54. Myanmar 12%
55. Neglected Diseases 8%
56. Pandemics 5%
57. Paromomycin 8%
58. Pentamidine 10%
59. picaridin 6%
60. Polymerase Chain Reaction 12%
61. Recurrence 11%
62. Referral and Consultation 7%
63. Retrospective Studies 12%
64. Routine Diagnostic Tests 14%
65. Safety 6%
66. Schistosoma 5%
67. Schistosomiasis 10%
68. Sensitivity and Specificity 6%
69. Sierra Leone 19%
70. Skin 6%
71. Sudan 5%
72. Survivors 6%
73. Therapeutics 15%
74. Treatment Failure 6%
75. Tropical Medicine 5%
76. Tuberculosis 14%
77. Vaccines 7%
78. Virus Diseases 6%
79. Visceral Leishmaniasis 85%
80. Zika Virus 15%
81. Zika Virus Infection 10%